Skip to main content
Log In
Sign Up
Home
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
Watchlist
Compare
107.34
-0.16 (-0.15%)
At close:
Aug 1, 2025, 4:00 PM
108.05
+0.71 (0.66%)
After-hours:
Aug 1, 2025, 7:38 PM EDT
Overview
Financials
Forecast
Statistics
Dividends
History
Profile
Chart
Income
Balance Sheet
Cash Flow
Ratios
KPIs
NEW
Annual
Quarterly
TTM
Revenue by Product
Fiscal year is January - December.
TTM
Download
Full Width
Fiscal Year
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
2017 - 2019
Period Ending
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Dec '20
Dec 31, 2020
2017 - 2019
COVID-19 Vaccine Revenue (Post-FY2023 Reporting)
2.43B
Log In
Log In
Log In
Log In
Upgrade
COVID-19 Vaccine Revenue (Post-FY2023 Reporting) Growth
-7.43%
Log In
Log In
Log In
Log In
Upgrade
Other Sales Revenue (Post-FY2023 Reporting)
319.00M
Log In
Log In
Log In
Log In
Upgrade
Other Sales Revenue (Post-FY2023 Reporting) Growth
229.45%
Log In
Log In
Log In
Log In
Upgrade
Research & Development
-
Log In
Log In
Log In
Log In
Upgrade
Research & Development Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other Sales Revenue (Pre-FY2024 Reporting)
-
Log In
Log In
Log In
Log In
Upgrade
Other Sales Revenue (Pre-FY2024 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
COVID-19 Vaccine Revenue (Pre-FY2024 Reporting)
-
Log In
Log In
Log In
Log In
Upgrade
COVID-19 Vaccine Revenue (Pre-FY2024 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
